The Possible Existence of Multiple Receptors for Substance P

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 1982 Mar 1

PMID 6176885

Citations 56

Authors

C M Lee

L L Iversen

M R Hanley

B E Sandberg

Affiliations

Soon will be listed here.

Abstract

1. The possible existence of multiple receptors for substance P (SP) was investigated by examining the relative pharmacological potencies of SP and related peptides in contracting guinea pig ileum, in potentiating electrically evoked contractions of rat vas deferens preparations and in competing for 3H-SP receptor binding in rat brain membranes, and by comparing the extent of cross-tachyphylaxis of various analogues with SP in the guinea pig ileum. 2. Different rank orders of potencies were observed among SP, its C-terminal fragments, analogues and related tachykinins in the different test systems, and these could not be explained by differential access to the target organ receptors. 3. In contrast to SP and physalaemin, both eledoisin and a metabolically stable SP analogue, [pGlu5, MePhe8, Sar9]-SP5-11 exhibited differential recovery from SP tachyphylaxis in the guinea pig ileum, and part of their spasmogenic action in this preparation was atropine-sensitive. 4. The results suggest the possible existence of multiple SP receptors, and the specificity of those in the brain may be different from those in the gut. The structural and pharmacological basis for subdividing tachykinins into SP-physalaemin and eledoisin-kassinin families is also discussed.

Citing Articles

Mast cell deficient and neurokinin-1 receptor knockout mice are protected from stress-induced hair growth inhibition.

Arck P, Handjiski B, Kuhlmei A, Peters E, Knackstedt M, Peter A J Mol Med (Berl). 2005; 83(5):386-96.

PMID: 15759104 DOI: 10.1007/s00109-004-0627-z.

Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways.

Arck P, Handjiski B, Peters E, Peter A, Hagen E, Fischer A Am J Pathol. 2003; 162(3):803-14.

PMID: 12598315 PMC: 1868104. DOI: 10.1016/S0002-9440(10)63877-1.

Effects of interactions of naturally-occurring neuropeptides on blood flow in the rat knee joint.

Lam F, Ferrell W Br J Pharmacol. 1993; 108(3):694-9.

PMID: 7682133 PMC: 1908032. DOI: 10.1111/j.1476-5381.1993.tb12863.x.

Sequence-specific effects of neurokinin substance P on memory, reinforcement, and brain dopamine activity.

Huston J, Hasenohrl R, Boix F, Gerhardt P, Schwarting R Psychopharmacology (Berl). 1993; 112(2-3):147-62.

PMID: 7532865 DOI: 10.1007/BF02244906.

Involvement of neurokinins in the non-cholinergic response to activation of 5-HT3 and 5-HT4 receptors in guinea-pig ileum.

Ramirez M, Cenarruzabeitia E, Del Rio J, Lasheras B Br J Pharmacol. 1994; 111(2):419-24.

PMID: 7516254 PMC: 1909981. DOI: 10.1111/j.1476-5381.1994.tb14751.x.

References

Erjavec F, Lembeck F, Skofitsch G, Donnerer J, Saria A, Holzer P . Release of histamine by substance P. Naunyn Schmiedebergs Arch Pharmacol. 1981; 317(1):67-70. DOI: 10.1007/BF00506259. View

Sandberg B, Lee C, Hanley M, Iversen L . Synthesis and biological properties of enzyme-resistant analogues of substance P. Eur J Biochem. 1981; 114(2):329-37. DOI: 10.1111/j.1432-1033.1981.tb05152.x. View

Holzer P, Lembeck F . Effect of neuropeptides on the efficiency of the peristaltic reflex. Naunyn Schmiedebergs Arch Pharmacol. 1979; 307(3):257-64. DOI: 10.1007/BF00505942. View

EULER U, Gaddum J . An unidentified depressor substance in certain tissue extracts. J Physiol. 1931; 72(1):74-87. PMC: 1403098. DOI: 10.1113/jphysiol.1931.sp002763. View

Gillespie J, McKnight A . The actions of some vasoactive polypeptides and their antagonists on the anococcygeus muscle. Br J Pharmacol. 1978; 62(2):267-74. PMC: 1667812. DOI: 10.1111/j.1476-5381.1978.tb08455.x. View

Lembeck F, Fischer G . [Crossed tachyphylaxis of peptides]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1967; 258(5):452-6. View

Nicoll R, Schenker C, Leeman S . Substance P as a transmitter candidate. Annu Rev Neurosci. 1980; 3:227-68. DOI: 10.1146/annurev.ne.03.030180.001303. View

Otsuka M, Konishi S, Takahashi T . Hypothalamic substance P as a candidate for transmitter of primary afferent neurons. Fed Proc. 1975; 34(10):1922-8. View

Bertaccini G . Active polypeptides of nonmammalian origin. Pharmacol Rev. 1976; 28(2):127-77. View

10.

Jensen R, Gardner J . Interaction of physalaemin, substance P, and eledoisin with specific membrane receptors on pancreatic acinar cells. Proc Natl Acad Sci U S A. 1979; 76(11):5679-83. PMC: 411713. DOI: 10.1073/pnas.76.11.5679. View

11.

MILENOV K, Oehme P, Bienert M, Bergmann J . Effect of substance P on mechanical and myoelectrical activities of stomach and small intestines in conscious dog. Arch Int Pharmacodyn Ther. 1978; 233(2):251-60. View

12.

Bury R, Mashford M . A pharmacological investigation of synthetic substance P on the isolated guinea-pig ileum. Clin Exp Pharmacol Physiol. 1977; 4(5):453-61. DOI: 10.1111/j.1440-1681.1977.tb02409.x. View

13.

Teichberg V, Cohen S, Blumberg S . Distinct classes of substance P receptors revealed by a comparison of the activities of substance P and some of its segments. Regul Pept. 1981; 1(5):327-33. DOI: 10.1016/0167-0115(81)90056-2. View

14.

Hanley M, Lee C, Michell R, Jones L . Similar effects of substance P and related peptides on salivation and on phosphatidylinositol turnover in rat salivary glands. Mol Pharmacol. 1980; 18(1):78-83. View

15.

ZETLER G, Kampmann E . An attempt to differentiate the effects of angiotensin II, substance P and bradykinin on the field-stimulated guinea-pig vas deferens. Eur J Pharmacol. 1979; 56(1-2):21-9. DOI: 10.1016/0014-2999(79)90428-x. View

16.

Blckwell M, James T, Starr M . Potentiation by substance P of contractions of the isolated vas deferens of the mouse elicited by electric field stimulation and by drugs. Br J Pharmacol. 1978; 63(2):323-9. PMC: 1668350. View

17.

KANETO A, Kaneko T, KAJINUMA H, Kosaka K . Effects of substance P and neurotensin infused intrapancreatically on glucagon and insulin secretion. Endocrinology. 1978; 102(2):393-401. DOI: 10.1210/endo-102-2-393. View

18.

Growcott J, Petter N . Tachyphylaxis due to the D-Phe7 analogue of substance P. J Pharm Pharmacol. 1980; 32(5):376-7. DOI: 10.1111/j.2042-7158.1980.tb12945.x. View

19.

Johnson A, Erdos E . Release of histamine from mast cells by vasoactive peptides. Proc Soc Exp Biol Med. 1973; 142(4):1252-6. DOI: 10.3181/00379727-142-37219. View

20.

Franco R, Costa M, Furness J . Evidence for the release of endogenous substance P from intestinal nerves. Naunyn Schmiedebergs Arch Pharmacol. 1979; 306(3):195-201. DOI: 10.1007/BF00507103. View